Hoffmann-La Roche Inc. v. Apotex Inc., No. 13-1128 (Fed. Cir. Apr. 11, 2014)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Plaintiff Hoffmann-La Roche , Inc., (“Roche”) appeals from the decision of the United States District Court for the District of New Jersey granting the defendant generic drug companies summary judgment of invalidity as to claims 1-8 of U.S. Patent No. 7,718,634 (“the ’634 patent”) and claims 1 -10 of U.S. Patent No. 7,410,957 (“the ’957 patent”). We affirm.